Brief: Lipigon Pharmaceuticals Q2 Operating Loss Widens To SEK 10.4 Mln

Lipigon Pharmaceuticals AB

26/08/2021 07:39

Aug 26 (Reuters) - Lipigon Pharmaceuticals AB  LPGO.ST :
    * Q2 NET SALES SEK 683,000 VERSUS SEK 438,000 YEAR AGO
    * Q2 OPERATING LOSS SEK 10.4 MILLION VERSUS LOSS SEK 1.6
MILLION
YEAR AGO

Source text for Eikon:  ID:nBQNbHPFXg 
Further company coverage:  LPGO.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))